# Xiao‐Jing Zhang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/xiao-jing-zhang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 10,446 |
| Field | Liver Disease Diagnosis and Treatment |
| h-index | 50 |
| i10-index | 119 |
| Last Known Institution | Guangzhou University of Chinese Medicine |
| OpenAlex ID | https://openalex.org/A5100432838 |
| ORCID iD | 0000-0002-8271-7405 |
| Works | 202 |

## Researcher papers

- [Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19](https://scholariq.org/papers/association-of-inpatient-use-of-angiotensin-converting-enzyme-inhibitors-and/)
- [Epidemiological Features of NAFLD From 1999 to 2018 in China](https://scholariq.org/papers/epidemiological-features-of-nafld-from-1999-to-2018-in-china/)
- [Neuronal injuries in cerebral infarction and ischemic stroke: From mechanisms to treatment (Review)](https://scholariq.org/papers/neuronal-injuries-in-cerebral-infarction-and-ischemic-stroke-from-mechanisms-to/)
- [Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta‐Analysis](https://scholariq.org/papers/unexpected-rapid-increase-in-the-burden-of-nafld-in-china-from-2008-to-2018-a/)
- [Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial](https://scholariq.org/papers/camrelizumab-versus-placebo-in-combination-with-gemcitabine-and-cisplatin-as/)
- [The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy](https://scholariq.org/papers/the-long-noncoding-rna-chaer-defines-an-epigenetic-checkpoint-in-cardiac/)
- [An ALOX12–12-HETE–GPR31 signaling axis is a key mediator of hepatic ischemia–reperfusion injury](https://scholariq.org/papers/an-alox12-12-hete-gpr31-signaling-axis-is-a-key-mediator-of-hepatic-ischemia/)
- [Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates](https://scholariq.org/papers/targeting-casp8-and-fadd-like-apoptosis-regulator-ameliorates-nonalcoholic/)
- [The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis](https://scholariq.org/papers/the-role-of-innate-immune-cells-in-nonalcoholic-steatohepatitis/)
- [The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis](https://scholariq.org/papers/the-deubiquitinating-enzyme-tnfaip3-mediates-inactivation-of-hepatic-ask1-and/)
- [Artesunate alleviates hepatic fibrosis induced by multiple pathogenic factors and inflammation through the inhibition of LPS/TLR4/NF-κB signaling pathway in rats](https://scholariq.org/papers/artesunate-alleviates-hepatic-fibrosis-induced-by-multiple-pathogenic-factors/)

## Researcher topics

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Hydrology and Watershed Management Studies](https://scholariq.org/topics/hydrology-and-watershed-management-studies/)
- [Peroxisome Proliferator-Activated Receptors](https://scholariq.org/topics/peroxisome-proliferator-activated-receptors/)
- [Endoplasmic Reticulum Stress and Disease](https://scholariq.org/topics/endoplasmic-reticulum-stress-and-disease/)
- [Diet, Metabolism, and Disease](https://scholariq.org/topics/diet-metabolism-and-disease/)

## Researcher university

- [Guangzhou University of Chinese Medicine](https://scholariq.org/institutions/guangzhou-university-of-chinese-medicine/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.